CC
PGEN icon

Chase Coleman’s Precigen PGEN Stock Holding History

Chase Coleman’s Portfolio PGEN Stock Details PGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-2,112,038
Closed -$70.9M – 24
2016
Q1 		$70.9M Buy
2,112,038
+421,963
+25% +$13.3M 1.02% 16
2015
Q4 		$50.5M Buy
+1,690,075
New +$57M 0.41% 24
2015
Q2 		– Sell
-313,900
Closed -$13.6M – 49
2015
Q1 		$13.6M Buy
+313,900
New +$11.3M 0.15% 42

Other funds holding PGEN

TS
Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MVP
Miller Value Partners Sarasota, Florida $423M AUM 49.14% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return

Chase Coleman's PGEN Position: Q2 2016 in Review

Chase Coleman sold out of Precigen (PGEN) in Q2 2016, closing a stake of 2,112,038 shares — an estimated $70.9M sold.

Chase Coleman first reported a position in PGEN in Q1 2015 and held it in 3 quarters. The position peaked at $70.9M in Q1 2016. 169 funds tracked by Wall St. Rank hold PGEN as of Q2 2016.

  • Chase Coleman reported no remaining Precigen position as of Q2 2016 after selling out during the quarter.
  • Chase Coleman sold 2,112,038 Precigen shares in Q2 2016, an estimated $70.9M.
  • Chase Coleman first reported a position in Precigen in Q1 2015 and held it in 3 quarters.
  • Chase Coleman's Precigen position peaked at $70.9M in Q1 2016.
  • 169 funds tracked by Wall St. Rank held Precigen as of Q2 2016.

Based on Tiger Global Management's 13F filing for Q2 2016, filed 15 Aug 2016.